Application Due Dates: on or after June 5, 2022 and subsequent receipt dates through July 5, 2025.
This Notice of Special Interest (NOSI) aims to accelerate a comprehensive understanding of the mechanisms of COVID-19-Associated Coagulopathy (CAC) which are provoked by vascular endothelial cell injury, hyperimmune responses, and hypercoagulability at genomic, molecular, and cellular levels.
Knowledge obtained from such studies may be applied to the future design of early diagnostics and effective treatment for high-risk patients as well as enable CAC research findings to be applied to on-going COVID-19 clinical trials.
Topics: Organ, Heart, Cardiovascular, Immunology, Host Response, Host Factors, Research Models, Non-Human Animal Models, Organoid Models, Mouse Models, Research Model Development, Research Methods, Sequencing, Screen, Immunofluorescence, Imaging, Cell Culture, Prognostics, Co-Morbidities, Immune Disorders, Inflammation, Immunosuppression, HIV, Rheumatoid Disorders, Diabetes, COVID-19, Cardiovascular Disease, Clinical Trial, Community Engagement, Social Determinants of Health, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Factors